International Validation of Two Non-motor Scales in PD (NFS and SPARK)
Recruiting · NCT04366804 · Observational (researchers observe without assigning treatment) · Lead sponsor: Insel Gruppe AG, University Hospital Bern
View the official record on ClinicalTrials.gov →What this trial is about
The goal of this project is to develop the international validation of two new rating scales, the Neuropsychiatric Fluctuations Scale (NFS) and the Shame in PARKinson's disease (SPARK) Scale, in order to improve the understanding of the extent and severity of non-motor symptoms in Parkinson's disease (PD).
Who can take part
Age range
30 Years to 75 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Written informed consent;
- PD, according to the MDS criteria;
- Age of participants \> 30 and \< 75 years;
- Being fluent in the language in which the scales are applied.
Exclusion criteria
- \. Presence of PD dementia (defined as MoCA score \< 24).
Where it is running
8 locations listed.
- Insel Gruppe AG University Hospital Bern - Bern, Switzerland
- Centre hospitalier régional universitaire de Besançon - Besançon, France
- Transilvania University - Brasov, Romania
- Hospital Universitario Burgos - Burgos, Spain
- Universitätsklinikum Carl Gustav Carus - Dresden, Germany
- King's College London - London, United Kingdom
- Ruber International Hospital - Madrid, Spain
- Aristotle University of Thessaloniki - Thessaloniki, Greece